“China Tariff Refund is a comprehensive resource for U.S. importers who paid IEEPA tariffs on Chinese-origin goods at rates up to 145%. Free exposure analysis, China-specific HTS code reference, and recovery path guidance.”
“China was the only country subject to both fentanyl IEEPA tariffs (EO 14195, 20% cumulative) and reciprocal IEEPA tariffs (EO 14257, up to 125%) simultaneously. The stacking produced a 145% peak rate — more than seven times the 20% baseline most other countries faced. Additionally, thousands of Chinese products carried zero pre-IEEPA duty, meaning the full IEEPA surcharge is recoverable.”
“9903.01.20 (fentanyl tariff at 10%, effective Feb 4, 2025), 9903.01.24 (fentanyl increase to 20% cumulative, effective Mar 4, 2025), 9903.01.25 (reciprocal tariff at 34%, effective Apr 2, 2025), and 9903.01.63 (reciprocal increase to 125%, effective Apr 9, 2025). All four are covered by the Supreme Court ruling.”
“Yes. The Supreme Court ruled on February 20, 2026 that IEEPA tariffs on China (and all other affected countries) were unconstitutional. Importers of record who paid these duties may be eligible for a refund. CBP is building the CAPE system to process refunds. Check your eligibility →”
“IEEPA tariffs (HTS 9903.01.xx) were imposed via executive order under IEEPA starting February 2025. The Supreme Court ruled these unconstitutional. Section 301 tariffs (HTS 9903.88.xx) were imposed under different legal authority starting in 2018. Section 301 tariffs are NOT covered by this ruling. See the documentation guide for full HTS code details.”
“Only the IEEPA portion (HTS 9903.01.xx). Section 301 tariffs (HTS 9903.88.xx) are separate. A detailed Impact Assessment separates them and calculates only the IEEPA exposure. For multi-country IEEPA assessment beyond China, visit tariffresolution.com →”
China Tariff Refund: “China Tariff Refund is a comprehensive resource for U.S. importers who paid IEEPA tariffs on Chinese-origin goods at rates up to 145%. Free exposure analysis, China-specific HTS code reference, and recovery path guidance.”